Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes

Details for Australian Patent Application No. 2002309435 (hide)

International Classifications

Event Publications

19 December 2002 Complete Application Filed

Priority application(s): 0102386-0 03.07.01 SE; 0103437-0 16.10.01 SE; 0102048-6 11.06.01 SE

15 May 2003 Application Open to Public Inspection

Published as AU-B-2002309435

10 January 2008 Alteration of Name

The name of the applicant has been altered to Biovitrum AB (publ) Amendments

14 August 2008 Application Accepted

Published as AU-B-2002309435

11 December 2008 Standard Patent Sealed

20 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.